We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 96

USPTO Says Overlapping Range In Prior Art Insufficient to Invalidate Method of Treatment Patent
  • Dechert LLP
  • USA
  • April 13 2018

Pharmaceutical patents frequently claim treatment methods that utilize a range of amounts or concentrations for the active ingredient or excipients


Federal Circuit Finds "Consisting Of" Requires Reversing Infringement Of Shire Lialda Patent
  • Foley & Lardner LLP
  • USA
  • February 14 2017

The Federal Circuit focused on the “consisting of” language in the claims at issue when it reversed the district court’s finding that Watson’s ANDA


Highlights on the draft rules of drug registration
  • King & Wood Mallesons
  • China
  • August 1 2016

On July 25, 2016, the China Food and Drug Administration ("CFDA") published the Administrative Provisions for Drug Registration (Revision) (the


Draft Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container
  • Hogan Lovells
  • European Union
  • April 21 2016

On 11 April 2016 a draft Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container (“the Draft


Formulation patent found not to be infringed as a redacted excipient was not a “pentahydric or hexahydric alcohol”
  • Borden Ladner Gervais LLP
  • Canada
  • April 22 2015

Apotex has successfully alleged that Teva’s patent to “Stable Compositions Containing Rasagiline” will not be infringed by Apotex’s use of a


Statements made during prosecution do not rise to the level of prosecution disclaimer unless unambiguous disavowal
  • Fitzpatrick, Cella, Harper & Scinto
  • USA
  • May 30 2014

When construing disputed claim terms in a patent infringement case, the claim terms are to be given “their ordinary and customary meaning as


Recent patent cases from the Federal Circuit - March 31 2014
  • Schwabe Williamson & Wyatt
  • USA
  • March 31 2014

Shire - The Circuit continues the trend since Ballast Lighting to reverse claim constructions - here the district court's overly broad construction


Federal Circuit patent bulletin: Shire Dev. LLC v. Watson Pharm., Inc.
  • Wiley Rein LLP
  • USA
  • March 28 2014

On March 28, 2014, in Shire Dev. LLC v. Watson Pharm., Inc., Inc., the U.S. Court of Appeals for the Federal Circuit (Rader, Prost, Hughes) reversed


Federal Court dismisses application for a prohibition order in respect of PATADAY eye drop solution
  • Norton Rose Fulbright Canada LLP
  • Canada
  • March 18 2014

This case concerns a proposed generic version of the brand name drug PATADAY, an eye drop solution used to treat allergic and inflammatory eye


Court of Cassation rules on Galenic exception
  • Jacobacci & Partners
  • Italy
  • December 18 2013

The Court of Cassation recently ruled on the scope of the so-called 'Galenic exception', which allows pharmacists to prepare prescription medicinal